文献速递流行病学与生物统计组学、生物样本库与精准医学

中国人群泛癌风险预测的多基因风险评分:基于中国嘉道理生物样本库的人群队列研究

Polygenic risk scores for pan-cancer risk prediction in the Chinese population: A population-based cohort study based on the China Kadoorie Biobank.
PubMed 文献 · PLoS Med · 2025-02-28

研究基于中国嘉道理生物样本库100,219名参与者,构建80个多基因风险评分(PRS)评估13种常见癌症风险。超过60%(50/80)的PRS与对应癌症结局显著相关,9种常见癌症的最优PRS每增加一个标准差与癌症风险显著相关(HR 1.20-1.76)。高遗传风险且可改变风险评分升高者癌症发病风险最高(HR 1.97-8.26),PRS与可改变风险因素分别解释了不同癌症的部分超额相对风险。

要点

  • 在100,219名中国人群中,80个PRS中超过60%(50/80)与对应癌症结局显著相关。
  • 9种常见癌症的最优PRS每增加一个标准差,与相应癌症风险显著相关(HR 1.20-1.76)。
  • 高遗传风险且可改变风险评分升高者癌症发病风险最高(HR 1.97-8.26)。

核心结论

  • 整合现有证据构建的PRS与中国人群9种常见癌症风险相关,可能改善临床风险评估。

研究设计与样本

  • 基于中国嘉道理生物样本库(CKB)的人群队列研究,纳入100,219名参与者,采用七种方案构建80个PRS评估13种最常见癌症。

主要发现

  • 超过60%(50/80)的PRS与对应癌症结局显著相关,识别出9种常见癌症的最优PRS,每增加一个标准差与相应癌症风险显著相关(HR 1.20-1.76)。
  • 与低遗传风险和可改变风险评分降低者相比,高遗传风险且可改变风险评分升高者癌症发病风险最高,HR从宫颈癌的1.97(95%CI 1.11-3.48,P=0.020)到前列腺癌的8.26(95%CI 1.92-35.46,P=0.005)。
  • 观察到9个PRS与癌症之间的显著交叉关联,整合PRS显著提高了多数癌症的预测准确性。
  • 在中国人群中,PRS解释了超额相对风险(ERR)的2.6%-20.3%,可改变风险因素解释了2.3%-16.7%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polygenic risk scores (PRSs) have been extensively developed for cancer risk prediction in European populations, but their effectiveness in the Chinese population remains uncertain. METHODS AND FINDINGS: We constructed 80 PRSs for the 13 most common cancers using seven schemes and evaluated these PRSs in 100,219 participants from the China Kadoorie Biobank (CKB). The optimal PRSs with the highest discriminatory ability were used to define genetic risk, and their site-specific and cross-cancer associations were assessed. We modeled 10-year absolute risk trajectories for each cancer across risk strata defined by PRSs and modifiable risk scores and quantified the explained relative risk (ERR) of PRSs with modifiable risk factors for different cancers. More than 60% (50/80) of the PRSs demonstrated significant associations with the corresponding cancer outcomes. Optimal PRSs for nine common cancers were identified, with each standard deviation increase significantly associated with corresponding cancer risk (hazard ratios (HRs) ranging from 1.20 to 1.76). Compared with participants at low genetic risk and reduced modifiable risk scores, those with high genetic risk and elevated modifiable risk scores had the highest risk of incident cancer, with HRs ranging from 1.97 (95% confidence interval (CI): 1.11-3.48 for cervical cancer, P = 0.020) to 8.26 (95% CI: 1.92-35.46 for prostate cancer, P = 0.005). We observed nine significant cross-cancer associations for PRSs and found the integration of PRSs significantly increased the prediction accuracy for most cancers. The PRSs contributed 2.6%-20.3%, while modifiable risk factors explained 2.3%-16.7% of the ERR in the Chinese population. CONCLUSIONS: The integration of existing evidence has facilitated the development of PRSs associated with nine common cancer risks in the Chinese population, potentially improving clinical risk assessment.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Zhu M, Zhu X, Han Y, et al. Polygenic risk scores for pan-cancer risk prediction in the Chinese population: A population-based cohort study based on the China Kadoorie Biobank. PLoS Med. 2025. PMID: 40019942. doi:10.1371/journal.pmed.1004534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。